scispace - formally typeset
T

Tim Waterboer

Researcher at German Cancer Research Center

Publications -  382
Citations -  11165

Tim Waterboer is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 45, co-authored 324 publications receiving 8836 citations.

Papers
More filters
Journal ArticleDOI

Bead-based multiplex genotyping of human papillomaviruses

TL;DR: Multiplex human papillomavirus genotyping (MPG), a quantitative and sensitive high-throughput procedure for the identification of multiple high- and low-risk genital HPV genotypes in a single reaction appears to be highly suitable for large-scale epidemiological studies and vaccination trials as well as for routine diagnostic purposes.
Journal ArticleDOI

Multiplex Human Papillomavirus Serology Based on In Situ-Purified Glutathione S-Transferase Fusion Proteins,

TL;DR: Using bead-based technology, multiplex serology enables antibody analyses of large numbers of sera against up to 100 antigens in parallel and has the potential to replace ELISA technology.
Journal ArticleDOI

Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer

TL;DR: The increased risk of oropharyngeal cancer among HPV16 E6 seropositive participants was independent of time between blood collection and diagnosis and was observed more than 10 years before diagnosis.
Journal ArticleDOI

Suppression of non-specific binding in serological Luminex assays.

TL;DR: In this paper, the authors show that serum pre-incubation with polyvinyl alcohol, polyvinylene glycol (P glycol) and a proprietary reagent (Super ChemiBlock, Chemicon) significantly reduced non-specific background.
Journal ArticleDOI

Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study.

TL;DR: In this article, the authors analyzed a cohort of COVID-19 patients prospectively, and found that neurocognitive long COVID symptoms can persist at least for one year after the symptom onset, and reduce life quality significantly.